T2D

Serial Number 86696547
602

Registration Progress

Application Filed
Jul 17, 2015
Under Examination
Approved for Publication
Published for Opposition
Registered

Trademark Image

T2D

Basic Information

Serial Number
86696547
Filing Date
July 17, 2015
Abandonment Date
November 28, 2016
Drawing Code
5000

Status Summary

Current Status
Inactive
Status Code
602
Status Date
Jan 3, 2017
Classes
044

Rights Holder

Intarcia Therapeutics, Inc.

03
Address
155 Seaport Blvd., Suite 11B
Boston, MA 02210

Ownership History

Intarcia Therapeutics, Inc.

Original Applicant
03
Boston, MA

Legal Representation

Attorney
Janet L. Cullum

USPTO Deadlines

All Deadlines Cleared

All 3 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

15 events
Date Code Type Description Documents
Jan 4, 2017 MAB2 O ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND Loading...
Jan 3, 2017 ABN2 O ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Loading...
May 24, 2016 CNFR R FINAL REFUSAL WRITTEN Loading...
May 24, 2016 GNFR O FINAL REFUSAL E-MAILED Loading...
May 24, 2016 GNFN O NOTIFICATION OF FINAL REFUSAL EMAILED Loading...
May 3, 2016 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
May 2, 2016 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
May 2, 2016 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Nov 3, 2015 CNRT R NON-FINAL ACTION WRITTEN Loading...
Nov 3, 2015 GNRT F NON-FINAL ACTION E-MAILED Loading...
Nov 3, 2015 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Oct 28, 2015 DOCK D ASSIGNED TO EXAMINER Loading...
Jul 24, 2015 MPMK E NOTICE OF PSEUDO MARK E-MAILED Loading...
Jul 23, 2015 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jul 20, 2015 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 044
Medical information services, namely, providing information on the topics of obesity and metabolic diseases/disorders and the diagnosis, treatment and management therapies relating thereto; providing information in the fields of medicine, drug delivery technologies, and administration of pharmaceuticals
First Use Anywhere: 0
First Use in Commerce: 0

Additional Information

Design Mark
The mark consists of capitalized three-dimensional letters T2D.
Color Claim
Color is not claimed as a feature of the mark.
Pseudo Mark
T TWO D

Classification

International Classes
044